Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing.

B. Larance,L. Degenhardt,N. Lintzeris,J. Bell,A. Winstock,P. Dietze,R. Mattick,R. Ali,D. Horyniak
DOI: https://doi.org/10.1016/j.drugalcdep.2011.04.002
IF: 4.852
2011-11-01
Drug and Alcohol Dependence
Abstract:
What problem does this paper attempt to address?